Key result
Turkey faces high cardiovascular mortality and ASCVD rates, driven by smoking, metabolic syndrome, and low HDL.
Why the study?
The prevalence of atherosclerotic vascular disease is unexpectedly high in Turkey despite its young population, with increasing risk factors such as smoking, metabolic syndrome, obesity, diabetes, and hypertension.
Highlights the high burden of atherosclerotic vascular disease and its risk factors in the young Turkish population, necessitating a National Heart Health Policy.
Supports urgent smoking cessation and metabolic screening in young Turkish adults; leaves open targeted prevention trials.
The prevalence of atherosclerotic vascular disease is unexpectedly high in Turkey despite its young population, with a median age of 29. The mean total cholesterol is lower than in Western European countries; however, smoking is very prevalent, the incidence of metabolic syndrome high and obesity, diabetes and hypertension are becoming a major problem, especially in women. Having these risk factors as well as lower HDL levels leads to high cardiovascular morbidity and mortality at younger ages. This problem is expected to become worse with increasing industrialisation, adaptation to Western diets, a sedentary lifestyle and increasing obesity. A National Heart Health Policy has been developed to overcome this epidemic and combat the risk factors and reduce the burden of atherosclerotic vascular disease.
No takes yet. Share an insight, caveat, or question.
Lale Tokgözo gcaron lu (2008) conducted a review in Atherosclerotic Vascular Disease. Cardiovascular risk factors was evaluated. Turkey has an unexpectedly high prevalence of atherosclerotic vascular disease and cardiovascular mortality despite a young population, primarily driven by high rates of smoking, metabolic syndrome, and low HDL levels.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: